Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/17/2009 | EP2068830A2 Modified two-component gelation systems for the treatment of post-myocardial infarction |
06/17/2009 | EP2068829A2 Semi-solid formulations of phospholipase enzyme inhibitors |
06/17/2009 | EP2068828A2 Biodegradable ocular implants and methods for treating ocular conditions |
06/17/2009 | EP2068827A2 Stabilization of lorazepam |
06/17/2009 | EP2068826A2 Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles |
06/17/2009 | EP2068825A1 Controlled release delivery system for nasal application of neurotransmitters |
06/17/2009 | EP2068824A2 High dose orally dissolvable/disintegrable lyophilized dosage form |
06/17/2009 | EP2068823A2 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
06/17/2009 | EP2068822A2 Self preserved aqueous pharmaceutical compositions |
06/17/2009 | EP2068821A2 Ophthalmic pharmaceutical compositions and uses thereof |
06/17/2009 | EP2068660A2 Stable polyunsaturated fatty acid emulsions and methods for inhibitintg, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
06/17/2009 | EP2068630A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
06/17/2009 | EP2068626A2 Composition for photoprotection |
06/17/2009 | EP1786468B1 Composition for promoting vascular smooth muscle relaxation |
06/17/2009 | EP1740154B1 Insulin compositions with improved absorption |
06/17/2009 | EP1633323B1 Ternary eutectic mixtures of local anesthetics |
06/17/2009 | EP1575656B1 Insulin delivery system with sensor |
06/17/2009 | EP1465652A4 Povidone-containing carriers for polypeptide growth factors |
06/17/2009 | EP1435786A4 Pesticidal formulations |
06/17/2009 | EP1425112B1 Method of manufacturing hydrogel particles of nano size |
06/17/2009 | EP1267883B1 Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin |
06/17/2009 | EP1004310B1 Gelled composition |
06/17/2009 | EP0947196B1 Sustained-release prostaglandin i derivative preparation |
06/17/2009 | CN201257161Y Composite isosorbide mononitrate sustained and controlled capsules |
06/17/2009 | CN101460156A Tansdermally absorbable preparation comprising anti-dementia agent |
06/17/2009 | CN101460155A Controlled release formulation of tolterodine |
06/17/2009 | CN101460154A Oral dosage forms including an antiplatelet agent and an acid inhibitor |
06/17/2009 | CN101460153A Non-homogenous dosage form coatings |
06/17/2009 | CN101460152A Compositions for the treatment and prevention of eyelid swelling |
06/17/2009 | CN101460151A Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same |
06/17/2009 | CN101460150A Directly compressible composite for orally disintegrating tablets |
06/17/2009 | CN101460149A Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water |
06/17/2009 | CN101460148A Solid dispersion of poorly soluble drugs in graft copolymers |
06/17/2009 | CN101460147A Drug microparticles |
06/17/2009 | CN101460146A Vesicular formulations containing organic acid prodrugs and process for their preparation |
06/17/2009 | CN101460145A Combination antidepressants wafer |
06/17/2009 | CN101460144A AchE-NMDA combination wafer |
06/17/2009 | CN101460143A Use of paliperidone for the treatment of sleep disturbances and/or excessive daytime sleepiness in psychiatric patients |
06/17/2009 | CN101460142A Extended release perforated tablet |
06/17/2009 | CN101455651A Skin paste capable of improving dementia, delusion and myasthenia due to cholinergic |
06/17/2009 | CN101455650A Percutaneous absorption patch and its production method |
06/17/2009 | CN101455649A Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
06/17/2009 | CN101455648A Puerarin freeze-drying preparation |
06/17/2009 | CN101455647A Gabexate mesylate freeze-drying preparation for Injection and preparation method thereof |
06/17/2009 | CN101455646A Meclofenoxate hydrochloride preparation freeze-drying technique and preparation method thereof |
06/17/2009 | CN101455645A Preparation method of medicine microspheres using plant soy protein as carrier |
06/17/2009 | CN101455644A Long-acting composite contraception microspheres and preparation method thereof |
06/17/2009 | CN101455643A Dry suspension and preparation method thereof |
06/17/2009 | CN101455642A Chitosan nano suspension and preparation method thereof |
06/17/2009 | CN101455641A Anti-cancer medicine liposome preparation sensitive to ray |
06/17/2009 | CN101455640A Composition containing taxone |
06/17/2009 | CN101455639A Acyclovir eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455638A Ribavirin eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455637A Bendazac lysine eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455636A Naphazoline hydrochloride, chlorphenamine maleate and vitamin B12 eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455635A Cromoglyn sodium eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455634A Composite aspartate, vitamin B6 and dipotassium glycyrrhetate eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455633A Disposable levofloxacin lactate eye drops without bacteria inhibitor and preparation method thereof |
06/17/2009 | CN101455632A Prescription of high-grade tranexamic acid injection and preparation technique thereof |
06/17/2009 | CN101455631A Meglumine cyclic adenosine injection and preparation technique thereof |
06/17/2009 | CN101455630A Chloromycetin eye drops containing sulfobutyl-beta-cyclodextrins and preparation method thereof |
06/17/2009 | CN101455629A Oral solid preparation containing omeprazole |
06/17/2009 | CN101455628A Gel composition for eyes and preparation method thereof |
06/17/2009 | CN100500275C Methods and apparatus for making particles using spray dryer and in-line jet mill |
06/17/2009 | CN100500221C Bioerodible film for ophthalmic drug delivery |
06/17/2009 | CN100500211C Methods of therapy with thrombin derived peptides |
06/17/2009 | CN100500200C Fuyankang pills against gynecologic inflammation and their preparation |
06/17/2009 | CN100500187C Chinese herbal medicine composition for dissolving stasis, lowering blood fat and blood pressure |
06/17/2009 | CN100500181C Capsules of Moyuqing for regulating digestive function |
06/17/2009 | CN100500164C Process for preparing bee glue water solution and use |
06/17/2009 | CN100500162C Anti-coronavirus agent |
06/17/2009 | CN100500157C Water-soluble medicine slow release tablet and its preparation method |
06/17/2009 | CN100500151C Water-soluble medicine sublingual-medicating formulation |
06/17/2009 | CN100500148C A buffered, liquid nicotine composition for pulmonary administration |
06/17/2009 | CN100500147C New formulations and use thereof |
06/17/2009 | CN100500140C Dermal compositions containing coenzyme Q as active ingredient |
06/17/2009 | CN100500139C External use medicine for treating rheumatic arthritis, and its preparation method |
06/17/2009 | CN100500138C Xiaoaiping preparation against cancers and its making method |
06/17/2009 | CN100500137C Film coating for tablets and caplets |
06/17/2009 | CN100500136C Effervescence tablet with honeysuckle, Chinese gold thread and forsythia fruit |
06/17/2009 | CN100500135C Medicine for treating menstrual irregularities and menalgia |
06/17/2009 | CN100500134C Preparation for improving bioavailability and effect of golden pheasant and preparation method and purpose thereof |
06/17/2009 | CN100500133C Chinese medicinal compound formulation for treating gynecopathy with improved bioavailability and drug effect and preparation process thereof |
06/17/2009 | CN100500132C Intravenous administered formulation of spreading hedyotis herb preparation method |
06/17/2009 | CN100500131C Granular powder for strengthening spleen and nourishing stomach and preparing method |
06/17/2009 | CN100500130C Sustained-release preparations and method for producing the same |
06/17/2009 | CN100500129C Aerosol combination |
06/17/2009 | CN100500128C Active carbon oral suspension liquid, preparing method and its use |
06/17/2009 | CN100500127C Compound sulfonamide suspension and its preparing process |
06/17/2009 | CN100500126C Sugar-free intensified loquat leaf mixture and preparation method thereof |
06/17/2009 | CN100500125C Method for making modulated release bioactive agents |
06/16/2009 | US7547759 Stimulating cytotoxic T-lymphocytes |
06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
06/16/2009 | US7547715 Treating lung diseases selected from acute pneumonia, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and asthma by administering (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7,8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof |
06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
06/16/2009 | US7547453 Method of production of material for treating mammalian joint maladies by biological fluid transplantation |
06/16/2009 | US7547452 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
06/16/2009 | US7547451 Comprises core and enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a derivative thereof; treatment of ulcerative colitis and Crohn's disease |
06/16/2009 | US7547449 using organic fluid-swellable, fibrous matrix, such as collagen, and a mineral phase such as caco3 or phosphate mineral phase to treat bone defects; once solidified a high mineral content can be achieved, with the inorganic mineral crystals embedded within the collagen fibers; synthetic bones |
06/16/2009 | US7547446 crosslinking gelatin with glutaraldehyde crosslinker in the presence of certain re-hydration aids, such as polyethylene glycol, polyvinylprovidone, and dextran; useful for providing hemostasis at surgical bleeding sites and traumatic bleeding site |